Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Wireless, Intermittent Monitoring of Right Heart Pressures in HF
- Conditions
- NYHA Class III Heart Failure
- First Posted Date
- 2010-07-15
- Last Posted Date
- 2015-01-19
- Lead Sponsor
- CardioMEMS
- Target Recruit Count
- 17
- Registration Number
- NCT01162707
- Locations
- 🇺🇸
Piedmont Hospital, Atlanta, Georgia, United States
🇺🇸Ohio State University Hospital, Columbus, Ohio, United States
🇺🇸Oklahoma Heart Hospital, Oklahoma City, Oklahoma, United States
EndoSure Sensor for Long-term Follow-up After Endovascular AAA Repair
- Conditions
- Aortic Aneurysm, Abdominal
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2012-08-30
- Lead Sponsor
- CardioMEMS
- Target Recruit Count
- 900
- Registration Number
- NCT00831870
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
- Conditions
- Heart Failure, Congestive
- First Posted Date
- 2007-09-19
- Last Posted Date
- 2015-01-28
- Lead Sponsor
- CardioMEMS
- Target Recruit Count
- 550
- Registration Number
- NCT00531661
- Locations
- 🇺🇸
CardioMEMS Investigational Sites, Nationwide, Georgia, United States
News
Abbott's TEAM-HF Trial Aims to Optimize Heart Failure Treatment with AI-Powered Monitoring
Abbott has initiated the TEAM-HF clinical trial to enhance outcomes for patients experiencing worsening heart failure by leveraging AI and the CardioMEMS™ HF System.
CardioMEMS Implant Halves Hospital Admissions for Heart Failure Patients
A tiny CardioMEMS sensor implanted in the pulmonary artery significantly reduces hospital admissions for heart failure patients by 44%.